Dr. Bela Kis is an interventional radiologist who works with mesothelioma patients as part of a multidisciplinary approach at the Moffitt Cancer Center in Tampa.
He is currently the lead investigator in a groundbreaking phase II transarterial chemoperfusion clinical trial for patients with unresectable pleural mesothelioma.
It involves identifying specific blood vessels that feed the tumors, then overloading those vessels with high doses of specific chemotherapy agents to stop the cancer growth without exposing the rest of the body.
He is heavily involved with image guided tumor therapy, image-guided biopsies and urinary and biliary interventions, arterial and venous stinting. He also does minimally invasive percutaneous tumor ablation.
Kis came to Moffitt after a residency and a fellowship at Brigham and Women’s Hospital in Boston. He attended medical school at the University of Szeged in Hungary and did another fellowship at Wake Forest Baptist Medical Center in North Carolina.